These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1355693)

  • 1. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
    Tadke RR; Suryavanshi P
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):131-2. PubMed ID: 16525085
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K; Leinonen E
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

  • 7. NMS after clozapine initiation.
    Skarpathiotakis M; Westreich N
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract]   [Full Text] [Related]  

  • 8. Case study: neuroleptic malignant syndrome without pyrexia.
    Hynes AF; Vickar EL
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ; Hopwood MJ; Morris PL
    Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    Sachdev P; Kruk J; Kneebone M; Kissane D
    J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large variations of plasma levels during maintenance treatment with depot neuroleptics.
    Tuninger E; Levander S
    Br J Psychiatry; 1996 Nov; 169(5):618-21. PubMed ID: 8932892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the predisposition to neuroleptic malignant syndrome genetically transmitted?
    Otani K; Horiuchi M; Kondo T; Kaneko S; Fukushima Y
    Br J Psychiatry; 1991 Jun; 158():850-3. PubMed ID: 1678666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent sinus arrest in association with neuroleptic malignant syndrome.
    Parry AK; Ormerod LP; Hamlin GW; Saleem PT
    Br J Psychiatry; 1994 May; 164(5):689-91. PubMed ID: 7921725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
    Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y
    J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.